A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(190 sites)

United States

University of Arizona Cancer Center, Tucson, Arizona

David Geffen School of Medicine at UCLA, Los Angeles, California

UC Irvine Health, Orange, California

Investigative Clinical Research of Indiana, Noblesville, Indiana

Beth Israel Deaconess Medical Center, Boston, Massachusetts